Search research articles
Contact Us
Filters
Showing results (21-30 of 294) with videos related to
Page
of 30
Sort By:
The New England Journal of Medicine
|
July 3, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumors
Theodoros Foukakis, John Lövrot, Jonas Bergh
Acta Oncologica (Stockholm, Sweden)
|
May 25, 2017
Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts
Alexios Matikas, Theodoros Foukakis, Jonas Bergh
Journal of the National Cancer Institute
|
April 5, 2018
RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis
Alexios Matikas, Theodoros Foukakis, Jonas Bergh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2016
Sisyphean Efforts: Establishing the Correct Risk-Benefit Balance for Adjuvant Therapies
Jonas Bergh, Kathleen I Pritchard, David Cameron
The New England Journal of Medicine
|
May 5, 2007
A gene signature in breast cancer
Kristian Wennmalm, Lance D Miller, Jonas Bergh
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 21, 2004
Quantitative assessment of skin erythema due to radiotherapy--evaluation of different measurements
Yvonne Wengström, Christina Forsberg, Ingemar Näslund, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 23, 2008
Radiological assessment of tumour response to anti-cancer drugs: time to reappraise
Peter Nygren, Lennart Blomqvist, Jonas Bergh, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Update of the oxford overview: new insight and perspectives in the era of personalized medicine
Kathleen I Pritchard, Jonas Bergh, Harold J Burstein
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 28, 2004
HER-2/neu (c-erbB-2) evaluation in primary breast carcinoma by fluorescent in situ hybridization and immunohistochemistry with special focus on intratumor heterogeneity and comparison of invasive and in situ components
Jenny Andersson, Barbro Linderholm, Jonas Bergh, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 10, 2010
Trastuzumab use in breast cancer patients in the six Health Care Regions in Sweden
Ulla Wilking, Bengt Jönsson, Nils Wilking, et al.
Page
of 30
Search research articles
Search
Showing results (21-30 of 294) with videos related to
Sort By:
Page
of 30
The New England Journal of Medicine
|
July 3, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumors
Theodoros Foukakis, John Lövrot, Jonas Bergh
Acta Oncologica (Stockholm, Sweden)
|
May 25, 2017
Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts
Alexios Matikas, Theodoros Foukakis, Jonas Bergh
Journal of the National Cancer Institute
|
April 5, 2018
RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis
Alexios Matikas, Theodoros Foukakis, Jonas Bergh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2016
Sisyphean Efforts: Establishing the Correct Risk-Benefit Balance for Adjuvant Therapies
Jonas Bergh, Kathleen I Pritchard, David Cameron
The New England Journal of Medicine
|
May 5, 2007
A gene signature in breast cancer
Kristian Wennmalm, Lance D Miller, Jonas Bergh
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 21, 2004
Quantitative assessment of skin erythema due to radiotherapy--evaluation of different measurements
Yvonne Wengström, Christina Forsberg, Ingemar Näslund, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 23, 2008
Radiological assessment of tumour response to anti-cancer drugs: time to reappraise
Peter Nygren, Lennart Blomqvist, Jonas Bergh, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Update of the oxford overview: new insight and perspectives in the era of personalized medicine
Kathleen I Pritchard, Jonas Bergh, Harold J Burstein
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 28, 2004
HER-2/neu (c-erbB-2) evaluation in primary breast carcinoma by fluorescent in situ hybridization and immunohistochemistry with special focus on intratumor heterogeneity and comparison of invasive and in situ components
Jenny Andersson, Barbro Linderholm, Jonas Bergh, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 10, 2010
Trastuzumab use in breast cancer patients in the six Health Care Regions in Sweden
Ulla Wilking, Bengt Jönsson, Nils Wilking, et al.
Page
of 30